During the past decade, Kentucky Heart Institute / King's Daughter conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kentucky Heart Institute / King's Daughter" #1 collaborator was "Northwestern University" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Kentucky Heart Institute / King's Daughter" are "Coronary Artery Disease" (2 trials), "Left Ventricular Dysfunction" (1 trials) and "Sudden Cardiac Death" (1 trials). Many other conditions were trialed in "Kentucky Heart Institute / King's Daughter" in a lesser frequency.

Most popular intervention types in "Kentucky Heart Institute / King's Daughter" are "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Control" (1 trials), "Defibrillator" (1 trials) and "Fortify® ST, Fortify Assura® ST, Ellipse® ST family of devices" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kentucky Heart Institute / King's Daughter" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kentucky Heart Institute / King's Daughter". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Kentucky Heart Institute / King's Daughter, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kentucky Heart Institute / King's Daughter, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".